Stock IMRX IMMUNEERING CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Immuneering Corporation

Equities

IMRX

US45254E1073

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-05-03 EDT 		5-day change 1st Jan Change
1.64 USD +5.13% Intraday chart for Immuneering Corporation +11.56% -77.69%
04-09 Immuneering Corporation Presents Preclinical Data At the American Association for Cancer Research Annual Meeting CI
04-02 Mizuho Adjusts Price Target on Immuneering to $8 From $20 on Revised Revenue Assumptions for Lead Asset IMM-1-104, Keeps Buy Rating MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. IMRX Stock
  4. News Immuneering Corporation
  5. Official Publications